Guardian Capital (Canada)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-4,026
Closed -$313K – 218
2016
Q3
$313K Sell
4,026
-316
-7% -$25.5K ﹤0.01% 179
2016
Q2
$339K Buy
4,342
+176
+4% +$14K 0.01% 164
2016
Q1
$341K Sell
4,166
-985
-19% -$80.1K 0.01% 168
2015
Q4
$460K Sell
5,151
-2,383
-32% -$202K 0.01% 149
2015
Q3
$579K Buy
7,534
+4,464
+145% +$373K 0.01% 151
2015
Q2
$257K Sell
3,070
-724
-19% -$63.9K ﹤0.01% 194
2015
Q1
$342K Buy
+3,794
New +$327K 0.01% 191
2014
Q2
– Sell
-6,124
Closed -$429K – 202
2014
Q1
$429K Sell
6,124
-3,804
-38% -$265K 0.01% 181
2013
Q4
$663K Buy
+9,928
New +$607K 0.01% 149

Other funds holding CAH

Guardian Capital (Canada)'s CAH Position: Q4 2016 in Review

Guardian Capital (Canada) sold out of Cardinal Health (CAH) in Q4 2016, closing a stake of 4,026 shares — an estimated $313K sold.

Guardian Capital (Canada) first reported a position in CAH in Q4 2013 and held it in 9 quarters. The position peaked at $663K in Q4 2013. 773 funds tracked by Wall St. Rank hold CAH as of Q4 2016.

  • Guardian Capital (Canada) reported no remaining Cardinal Health position as of Q4 2016 after selling out during the quarter.
  • Guardian Capital (Canada) sold 4,026 Cardinal Health shares in Q4 2016, an estimated $313K.
  • Guardian Capital (Canada) first reported a position in Cardinal Health in Q4 2013 and held it in 9 quarters.
  • Guardian Capital (Canada)'s Cardinal Health position peaked at $663K in Q4 2013.
  • 773 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2016.

Based on Guardian Capital (Canada)'s 13F filing for Q4 2016, filed 14 Feb 2017.